JPH1160551A5 - - Google Patents

Info

Publication number
JPH1160551A5
JPH1160551A5 JP1998162706A JP16270698A JPH1160551A5 JP H1160551 A5 JPH1160551 A5 JP H1160551A5 JP 1998162706 A JP1998162706 A JP 1998162706A JP 16270698 A JP16270698 A JP 16270698A JP H1160551 A5 JPH1160551 A5 JP H1160551A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
integer
substituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998162706A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1160551A (ja
JP4177483B2 (ja
Filing date
Publication date
Priority claimed from DE19719621A external-priority patent/DE19719621A1/de
Application filed filed Critical
Publication of JPH1160551A publication Critical patent/JPH1160551A/ja
Publication of JPH1160551A5 publication Critical patent/JPH1160551A5/ja
Application granted granted Critical
Publication of JP4177483B2 publication Critical patent/JP4177483B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP16270698A 1997-05-09 1998-05-08 スルホニルアミノカルボン酸 Expired - Fee Related JP4177483B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19719621:7 1997-05-09
DE19719621A DE19719621A1 (de) 1997-05-09 1997-05-09 Sulfonylaminocarbonsäuren

Publications (3)

Publication Number Publication Date
JPH1160551A JPH1160551A (ja) 1999-03-02
JPH1160551A5 true JPH1160551A5 (enExample) 2005-09-29
JP4177483B2 JP4177483B2 (ja) 2008-11-05

Family

ID=7829102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16270698A Expired - Fee Related JP4177483B2 (ja) 1997-05-09 1998-05-08 スルホニルアミノカルボン酸

Country Status (20)

Country Link
US (2) US6451824B1 (enExample)
EP (1) EP0877018B1 (enExample)
JP (1) JP4177483B2 (enExample)
KR (1) KR100572494B1 (enExample)
CN (1) CN1280267C (enExample)
AR (1) AR012674A1 (enExample)
AT (1) ATE238984T1 (enExample)
AU (1) AU732723B2 (enExample)
BR (1) BR9801606B1 (enExample)
CA (1) CA2237099C (enExample)
CZ (1) CZ295527B6 (enExample)
DE (2) DE19719621A1 (enExample)
DK (1) DK0877018T3 (enExample)
ES (1) ES2195220T3 (enExample)
HU (1) HU224959B1 (enExample)
ID (1) ID20807A (enExample)
PL (1) PL191876B1 (enExample)
PT (1) PT877018E (enExample)
RU (1) RU2193027C2 (enExample)
TR (1) TR199800815A3 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL342009A1 (en) 1998-02-04 2001-05-07 Novartis Ag Sulphonylamine derivatives capable to inhibit extracellular substance degrading metaloproteinases
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
EP1097159B1 (de) 1998-07-16 2002-11-06 Aventis Pharma Deutschland GmbH Phosphin- und phosphonsäurederivate als arzneimittel
DE19851184A1 (de) 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6677360B2 (en) 1998-12-16 2004-01-13 Bayer Aktiengesellschaft Biphenyl and biphenyl-analogous compounds as integrin antagonists
US6420396B1 (en) * 1998-12-16 2002-07-16 Beiersdorf Ag Biphenyl and biphenyl-analogous compounds as integrin antagonists
US6492394B1 (en) * 1998-12-22 2002-12-10 Syntex (U.S.A.) Llc Sulfonamide hydroxamates
SK12462001A3 (sk) 1999-03-03 2002-04-04 The Procter & Gamble Company Inhibítory metaloproteáz
AU3196200A (en) * 1999-03-26 2000-10-16 Shionogi & Co., Ltd. Beta-amino acid derivatives
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
RU2245876C2 (ru) 2000-03-21 2005-02-10 Дзе Проктер Энд Гэмбл Компани Производные сульфонамидов и фармацевтическая композиция на их основе
CA2401728A1 (en) 2000-03-21 2001-09-27 The Procter & Gamble Company Difluorobutyric acid metalloprotease inhibitors
PL357250A1 (en) * 2000-03-21 2004-07-26 The Procter & Gamble Company Heterocyclic side chain containing metalloprotease inhibitors
US6548667B2 (en) * 2000-04-07 2003-04-15 Samsung Electronics Co. Ltd. Sulfonamide derivative as a matrix metalloproteinase inhibitor
GB0103303D0 (en) * 2001-02-09 2001-03-28 Novartis Ag Organic compounds
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
US7071223B1 (en) * 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
EP1626962B1 (en) * 2003-05-12 2007-02-28 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
EP1493740A1 (fr) * 2003-07-03 2005-01-05 Warner-Lambert Company LLC Dérivés de 5-fluoro-thiophene, leur procédé de preparation, les compositions pharmaceutiques les contenant et leur utilisation comme inhibiteurs de métalloprotéinases
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
GB0412553D0 (en) * 2004-06-04 2004-07-07 Univ Aberdeen Therapeutic agents for the treatment of bone conditions
CA2572118A1 (en) * 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid
CN1980902A (zh) * 2004-06-29 2007-06-13 辉瑞产品有限公司 通过对羟基保护前体去保护而制备5－4－(2－羟基－丙基)－3，5－二氧代－4，5－二氢－3h－[1，2，4]三嗪－2－基－苯甲酰胺衍生物的方法
BRPI0512915A (pt) * 2004-06-29 2008-04-15 Warner Lambert Co terapias de combinação utilizando inibidores benzamida do receptor p2x7
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
GB0705400D0 (en) 2007-03-21 2007-05-02 Univ Aberdeen Therapeutic compounds andm their use
SA08290668B1 (ar) * 2007-10-25 2012-02-12 شيونوجي آند كو.، ليمتد مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها
GB0817207D0 (en) 2008-09-19 2008-10-29 Pimco 2664 Ltd therapeutic apsac compounds and their use
GB0817208D0 (en) 2008-09-19 2008-10-29 Pimco 2664 Ltd Therapeutic apsap compounds and their use
ES2575689T3 (es) * 2008-12-23 2016-06-30 Aquilus Pharmaceuticals, Inc Compuestos y métodos para el tratamiento del dolor y otras enfermedades
GB201311361D0 (en) 2013-06-26 2013-08-14 Pimco 2664 Ltd Compounds and their therapeutic use
HUE057569T2 (hu) 2014-12-17 2022-05-28 Pimco 2664 Ltd N-(4-hidroxi-4-metil-ciklohexil)-4-fenil-benzolszulfonamid és N-(4-hidroxi-4-metil-ciklohexil)-4-(2-piridil)-benzolszulfonamid vegyületek és terápiás alkalmazásuk

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764262B2 (ja) * 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (enExample) * 1990-07-05 1993-03-01 Hoffmann La Roche
GB9200210D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
AU690703B2 (en) * 1994-06-22 1998-04-30 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CA2218503C (en) * 1995-04-20 2001-07-24 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
KR980009238A (ko) * 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
SK282833B6 (sk) * 1995-11-17 2002-12-03 Warner-Lambert Company Sulfónamidové inhibítory matricových metaloproteináz a farmaceutická kompozícia obsahujúca tieto inhibítory
CA2242416C (en) * 1996-01-23 2006-03-21 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
NZ325939A (en) * 1996-01-23 2000-06-23 Shionogi & Co Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives
CZ294063B6 (cs) * 1996-05-17 2004-09-15 Warner-Lambert Company Bifenylsulfonamid, jeho použití a farmaceutický prostředek s jeho obsahem
US5756545A (en) * 1997-04-21 1998-05-26 Warner-Lambert Company Biphenysulfonamide matrix metal alloproteinase inhibitors
ATE210639T1 (de) * 1997-05-09 2001-12-15 Hoechst Ag Substituierte diaminocarbonsäuren

Similar Documents

Publication Publication Date Title
JPH11228529A5 (enExample)
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
KR910019989A (ko) 비스-아릴 아미드 및 우레아 화합물들, 이들로 구성된 조성물 이들을 이용한 paf 억제 방법 및 이들의 생산 방법
JPH10316662A5 (enExample)
JP2004521124A5 (enExample)
RU2008119651A (ru) Производные дикарбоновых кислот и их применение
JP2004525117A5 (enExample)
JP2009523146A5 (enExample)
TR201901246T4 (tr) Kimyasal bileşikler.
HUP0203902A2 (hu) Szubsztituált oxazolidinonok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
KR930005992A (ko) 루코트리엔 생합성 억제제
RU2012109545A (ru) Использование лигандов ppar дельта для лечения или предотвращения воспалений или заболеваний, связанных с метаболизмом/выработкой энергии
JP2005538944A5 (enExample)
NO20054791D0 (no) Forbindelser for behandling av stoffskiftesykdommer
JP2002514649A5 (enExample)
SE8702330L (sv) Foreningar avsedda att anvendas som mellanprodukt for framstellning av 3-amino-2-oxo-azetidin-1-sulfonsyror
HUP0001603A2 (hu) Cikloalkil-alkánkarbonsavamidok, előállításuk és alkalmazásuk
JP2006517201A5 (enExample)
RU94011232A (ru) Соли щелочноземельных металлов, соли переходных металлов и комплексы переходных металлов кетокарбоновых кислот в качестве ингибиторов коррозии
HUP9900804A2 (hu) Tumorellenes hatással rendelkező fenoxi-ecetsav- és fenoxi-metil-tetrazol-származékok alkalmazása gyógyszerkészítmények előállítására és új vegyületek
KR910004569A (ko) 고리형 치환체를 갖는 (퀴놀린-2-일-메톡시)페닐아세트산 유도체
UA72945C2 (uk) Сполука (варіанти), фармацевтична композиція, спосіб лікування (варіанти)
KR830001263A (ko) 화합물의 제조방법
DE69828516D1 (de) (hetero)aryl-sulfonamid derivate, deren herstellung und deren verwenddung als faktor xa inhibitoren
RU2010136324A (ru) Циклические индол-3-карбоксамиды, их получение и их применение в качестве лекарственных препаратов